Clinical trial
An Open-Label, Multicenter Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)
NCT05112965 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Multicenter Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- December 1, 2021
- Completion date
- June 30, 2027
- Enrollment
- 49 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.